Biol. Chem., Vol. 380, pp. 647– 652, June 1999 · Copyright © by Walter de Gruyter · Berlin · New York
Dequalinium
TM
Vesicles Form Stable
Complexes with Plasmid DNA which Are Protected
from DNase Attack
Jürgen Lasch
1,
*, Axel Meye
2
, Helge Taubert
2
,
Regine Koelsch
1
, Jasadee Mansa-ard
1
and
Volkmar Weissig
3
1
Institute of Physiological Chemistry,
2
Institute of Pathology, Martin-Luther-University Halle,
D-06097 Halle/Saale, Germany
3
Northeastern University, Bouve College of Pharmacy,
Boston, MA 02115, USA
* Corresponding author
Upon sonication, the antimicrobial and antineoplastic
compound dequalinium
TM
forms vesicles (DQAsomes,
Weissig et al., 1998). Dequalinium
TM
(1,1-(1,10-de-
camethylene-bis-[aminoquinaldinium])-chloride) was
shown to be a fluorophore with an emission maximum
at 366 nm. Addition of DNA results in a characteristic
quenching of its intrinsic fluorescence. After density
gradient centrifugation a band of dequalinium
TM
(DQA)
tightly associated with DNA is located between the
DNA and DQA bands. DQA/DNA-complexes contain-
ing plasmid DNA at a molar ratio of DQA/DNA 6:1 are
completely protected against DNase activity. Addition
of negatively-charged lipids release intact DNA in the
same manner as from cationic lipid/DNA complexes.
As regards biological effects, DQAsomes show a dif-
ferential cytotoxicity for normal and sarcoma cell
lines. In vitro incubation with fluorescein-labeled
oligodeoxynucleotides (5 -fluorescein-[GATC]
5
) showed
an increased uptake of the tagged oligodeoxynu-
cleotide if complexed with dequalinium.
We hypothesize that the DQA/DNA complexes are
well-suited for ‘DQAsomal gene transfer’ in vitro and
in vivo. Noteworthy, they display an intrinsic antitumor
activity manifested by differential cytotoxicity for nor-
mal and sarcoma cells.
Key words: Antineoplastic DNA vehicle / Bolaamphiphile /
Dequalinium / DNA / DNase-attack protection /
DQA-complexes / DQAsomal gene transfer.
Introduction
The divalent cation dequalinium
TM
(DQA) is a potent and
selective blocker of Ca
2+
-activated, small conductance
K
+
-channels (Castle et al., 1993), an anti-microbial agent
and has remarkable cancerostatic activities (Weiss et al.,
1987).
DQA is a bolaform molecule with two delocalized posi-
tive charges separated by a lipophilic spacer (Figure 1),
i.e.a single chain synthetic bolaamphiphile.
It accumulates in mitochondria (Bodden et al., 1986,
Weiss et al., 1987) like other lipophilic cations as a result of
the relatively high electrical potential (–160 to –180 mV)
across the mitochondrial membrane and strongly inhibits
mitochondrial F1-ATPase and protein kinase C (Roten-
berg et al., 1990; Moriyama et al., 1995).
There is, however, still no consensus about the molecu-
lar targets of this compound. Its anticarcinoma activity is
based on increased accumulation and retention in malig-
nant epithelial cells (Christman et al., 1990). DQA affects
proliferation in highly metastatic melanoma cells and their
motility and invasion as well (Helige et al., 1992). In addi-
tion, it was shown to be more effective and less toxic in
inhibiting growth of intraperitoneally implanted mouse
carcinomas than other antineoplastic drugs like cisplatin,
doxorubicin, 5-fluorouracil (Sweet and Singh, 1995). In
line with these pharmacological effects it has some in vitro
and in vivo cytotoxicity.
Recently, we discovered that liposomal structures can
be prepared from DQA, dubbed DQAsomes (Weissig et
al., 1998). Here we describe more characteristics of these
bolaform molecule vesicles and show that DQAsomes
can efficiently bind plasmid DNA and protect it from de-
oxyribonuclease-I digestion in vitro. The DQA/DNA com-
plexes, which have much in common with the lipoplexes
of DNA, were studied as potential DNA transport vehicles.
Results
Freeze-fracture electron microscopy showed unambigu-
ously that dequalinium can form spherical vesicles (Weis-
sig et al., 1998).
Fig. 1 Chemical Structure of Dequalinium
TM
.
Brought to you by | The University of Auckland Library
Authenticated
Download Date | 5/17/15 3:12 AM